Author

D. Kopinke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:fluorescence / live-cell microscopy· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

A. Franceschini Ghilardi· 1 shared A. N. Zuniga· 1 shared A. Riva· 1 shared B. Davis· 1 shared B. Law· 1 shared C. Gunaratne· 1 shared C. Heldermon· 1 shared C. Jobin· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Franceschini Ghilardi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer

Y. Feng, R. C. Newsome, T. Robinson, R. L. Bowman, A. N. Zuniga, K. N. Hall, C. M. Berntsen, D. E. Shabashvili, K. I. Krajcik, C. Gunaratne, Z. J. Zaroogian, K. Venugopal, H. L. Casellas Roman, R. L. Levine, W. K. Chatila, , O. A. Guryanova

This study shows that hematopoietic Dnmt3a haploinsufficiency worsens colitis-associated colon cancer by promoting angiogenesis, which can be targeted with axitinib.

bioRxiv · Dec 30, 2022 · PreprintCancer Biology

An Optimized Approach to Study Sub-Sarcomere Structure Utilizing Super-Resolution Microscopy with Secondary VHH Nanobodies

C. M. Douglas, J. E. Bird, D. Kopinke, K. A. Esser

This study develops a method to visualize sub-sarcomere structures using optimized super-resolution microscopy and VHH nanobodies, enabling precise protein localization analysis in skeletal muscle.

bioRxiv · Sep 7, 2022 · PreprintPhysiology

Mechanistic Elucidation of the Antitumor Properties of a Novel Death Receptor 5 Activator

M. Wang, M. Law, B. Davis, E. Yaaghubi, A. Franceschini Ghilardi, R. Ferreira, C.-W. Chiang, O. Guryanova, D. Kopinke, C. Heldermon, R. Castellano, B. Law

This study identifies DDAs as compounds that upregulate DR5 in cancer cells, leading to apoptosis and synergy with TRAIL, with selectivity for oncogene-transformed cells.

bioRxiv · Jul 14, 2019 · PreprintCancer Biology